These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 2794100)

  • 1. Relationship of triazolam clearance to alpha-1 acid glycoprotein concentrations.
    Kroboth PD; Smith RB
    J Clin Psychopharmacol; 1989 Oct; 9(5):380-1. PubMed ID: 2794100
    [No Abstract]   [Full Text] [Related]  

  • 2. Triazolam protein binding and correlation with alpha-1 acid glycoprotein concentration.
    Kroboth PD; Smith RB; Sorkin MI; Silver MR; Rault R; Garry M; Juhl RP
    Clin Pharmacol Ther; 1984 Sep; 36(3):379-83. PubMed ID: 6147221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated alpha-1-acid glycoprotein reduces the volume of distribution and systemic clearance of saquinavir.
    Holladay JW; Dewey MJ; Michniak BB; Wiltshire H; Halberg DL; Weigl P; Liang Z; Halifax K; Lindup WE; Back DJ
    Drug Metab Dispos; 2001 Mar; 29(3):299-303. PubMed ID: 11181499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha 1 -acid glycoprotein and binding of basic drugs.
    Paxton JW
    Methods Find Exp Clin Pharmacol; 1983 Nov; 5(9):635-48. PubMed ID: 6366403
    [No Abstract]   [Full Text] [Related]  

  • 5. Hemodialysis clearance of total and unbound lidocaine.
    Jacobi J; McGory RW; McCoy H; Matzke GR
    Clin Pharm; 1983; 2(1):54-7. PubMed ID: 6883930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Binding of perazine metabolites and phenothiazine derivatives to acid alpha 1-glycoprotein].
    Schley J
    Arzneimittelforschung; 1983; 33(2):185-7. PubMed ID: 6133521
    [No Abstract]   [Full Text] [Related]  

  • 7. Triazolam biotransformation by human liver microsomes in vitro: effects of metabolic inhibitors and clinical confirmation of a predicted interaction with ketoconazole.
    von Moltke LL; Greenblatt DJ; Harmatz JS; Duan SX; Harrel LM; Cotreau-Bibbo MM; Pritchard GA; Wright CE; Shader RI
    J Pharmacol Exp Ther; 1996 Feb; 276(2):370-9. PubMed ID: 8632299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of drugs with a quaternary ammonium group to alpha-1 acid glycoprotein and asialo alpha-1 acid glycoprotein.
    van der Sluijs P; Meijer DK
    J Pharmacol Exp Ther; 1985 Sep; 234(3):703-7. PubMed ID: 4032288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Interaction of drugs with alpha 1-acid glycoprotein (orosomucoid)].
    Bender KI; Lutsevich AN
    Farmakol Toksikol; 1987; 50(5):110-9. PubMed ID: 3319686
    [No Abstract]   [Full Text] [Related]  

  • 10. Experimental demonstration in the rat of the role played by human alpha 1 glycoprotein (HAAG) in the nonlinearity of RU 486 pharmacokinetics in women.
    Tremblay D; Busigny M; Bonnat C; Pottier J
    Prog Clin Biol Res; 1989; 300():441-4. PubMed ID: 2528733
    [No Abstract]   [Full Text] [Related]  

  • 11. Ethnic differences in reactions to drugs and xenobiotics. Other protein variants with pharmacogenetic consequences: albumin and orosomucoid.
    Alván G
    Prog Clin Biol Res; 1986; 214():345-55. PubMed ID: 3523512
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of albumin and alpha-1 acid glycoprotein on elimination of prazosin and antipyrine in the isolated perfused rat liver.
    Oie S; Fiori F
    J Pharmacol Exp Ther; 1985 Sep; 234(3):636-40. PubMed ID: 4032284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of taxol to human plasma, albumin and alpha 1-acid glycoprotein.
    Kumar GN; Walle UK; Bhalla KN; Walle T
    Res Commun Chem Pathol Pharmacol; 1993 Jun; 80(3):337-44. PubMed ID: 8102493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum alpha 1-acid glycoprotein level in chronic hemodialysis patients.
    Yorioka N; Wada K; Hamaguchi N; Kobayashi M; Shigemoto K; Hirabayashi A; Miyamori S; Toyota T; Hayashi K; Tada M
    Hiroshima J Med Sci; 1984 Sep; 33(3):377-81. PubMed ID: 6511463
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of triazolam clearance by macrolide antimicrobial agents: in vitro correlates and dynamic consequences.
    Greenblatt DJ; von Moltke LL; Harmatz JS; Counihan M; Graf JA; Durol AL; Mertzanis P; Duan SX; Wright CE; Shader RI
    Clin Pharmacol Ther; 1998 Sep; 64(3):278-85. PubMed ID: 9757151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The kinetics of induction by rifampin of alpha 1-acid glycoprotein and antipyrine clearance in the dog.
    Abramson FP; Lutz MP
    Drug Metab Dispos; 1986; 14(1):46-51. PubMed ID: 2868864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of the alpha1-acid glycoprotein binding of azithromycin in vitro by equilibrium dialysis.
    Gastearena I; Dios-Vieitez MC; Terraz MM; Domingo S; Fos D
    J Chemother; 1995 Nov; 7 Suppl 4():26-8. PubMed ID: 8904095
    [No Abstract]   [Full Text] [Related]  

  • 18. Ketoconazole inhibition of triazolam and alprazolam clearance: differential kinetic and dynamic consequences.
    Greenblatt DJ; Wright CE; von Moltke LL; Harmatz JS; Ehrenberg BL; Harrel LM; Corbett K; Counihan M; Tobias S; Shader RI
    Clin Pharmacol Ther; 1998 Sep; 64(3):237-47. PubMed ID: 9757147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug binding to human alpha-1-acid glycoprotein in health and disease.
    Kremer JM; Wilting J; Janssen LH
    Pharmacol Rev; 1988 Mar; 40(1):1-47. PubMed ID: 3064105
    [No Abstract]   [Full Text] [Related]  

  • 20. Blood levels of a pteridine-binding alpha 1-acid glycoprotein in cancer patients.
    Fink M; Ziegler I; Maier K; Wilmanns W
    Cancer Res; 1982 Apr; 42(4):1574-8. PubMed ID: 7060027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.